Clinical Trial Update: Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis [Phase 2]

View source ↗

Summary

A multicenter Phase 2 trial evaluating the safety and efficacy of adalimumab in adults with moderate to severe chronic plaque psoriasis has completed. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: Abbott | Conditions: Psoriasis | Phase 2 | Status: COMPLETED